How are Companion Diagnostics Considered in Economic Evaluations of Oncology Treatments? A Review of Health Technology Assessments

BACKGROUND: Companion diagnostic (CDx) testing is increasingly used to identify eligible patients for targeted treatments. Guidance on how CDx testing should be incorporated into cost-effectiveness models (CEM) is limited. This review evaluated how health technology assessment bodies and research or...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez Montero, Melissa, El Alili, Houcine, Hashim, Mahmoud, Wigfield, Peter, Dimova, Mariya, Riley, Ralph, Pascoe, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440183/
https://www.ncbi.nlm.nih.gov/pubmed/35790681
http://dx.doi.org/10.1007/s41669-022-00350-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440183/
https://www.ncbi.nlm.nih.gov/pubmed/35790681
http://dx.doi.org/10.1007/s41669-022-00350-6

Ejemplares similares